Windtree Therapeutics Inc...

NASDAQ: WINT · Real-Time Price · USD
0.51
-0.01 (-1.28%)
At close: Aug 15, 2025, 3:57 PM
0.51
-1.07%
After-hours: Aug 15, 2025, 07:58 PM EDT

Windtree Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 23.68M 23.68M 23.68M
Cost of Revenue
n/a n/a 22K 36K 156K 156K 269K 386K 421K 1.06M 1.15M 1.24M 1.29M 869K 12.48M 16.15M 20.43M
Gross Profit
n/a n/a -22K -36K -156K -156K -269K -386K -421K -1.06M -1.15M -1.24M -1.29M -869K 11.19M 7.53M 3.25M
Operating Income
-25.82M -26.14M -25.56M -25.51M -20.81M -20.6M -26.45M -26.41M -37.19M -41.33M -45.21M -48.71M -76.53M -77.28M -69.55M -70.11M -32.69M
Interest Income
47K 70K 123K 223K 311K 325K 316K 243K 152K 109K 58K 20K 42K 91K 97K 117K 83K
Pretax Income
-16.17M -1.79M -9.64M -11.07M -5.85M -20.29M -26.2M -25.83M -36.56M -40.58M -44.24M -48.4M -76.79M -77.62M -70.35M -71.16M -34.99M
Net Income
-16.05M -1.79M -9.71M -11.38M -5.96M -20.29M -24.83M -23.87M -34.39M -38.2M -41.58M -46.34M -66.6M -67.64M -62.02M -62.82M -34.99M
Selling & General & Admin
8.41M 8.74M 8.42M 8.23M 9.06M 9.2M 9.53M 9.61M 10.09M 10.79M 11.51M 12.33M 12.79M 14.47M 14.93M 16.29M 16.37M
Research & Development
16.29M 16.25M 17.09M 17.24M 9.14M 8.32M 6.5M 5.94M 7.17M 11.1M 14.36M 17.5M 18.72M 17.79M 16.85M 16.05M 16.32M
Other Expenses
1.12M 1.12M n/a n/a -39K 445K 159K 728K 968K 702K 964K 342K -211K -320K -792K -1.03M -2.26M
Operating Expenses
25.82M 26.14M 25.54M 25.48M 18.21M 18M 16.52M 16.03M 17.75M 21.89M 25.87M 29.82M 31.51M 32.26M 31.78M 32.34M 32.69M
Interest Expense
242K 235K 186K 148K 51K 50K 51K 52K 52K 53K 53K 53K 86K 114K 105K 137K 122K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
25.82M 26.14M 25.56M 25.51M 18.24M 18.02M 16.52M 16.03M 17.75M 21.89M 25.87M 29.82M 31.51M 32.26M 31.78M 32.34M 32.69M
Income Tax Expense
-120K -6K 71K 311K 114K n/a -1.37M -1.96M -2.17M -2.37M -2.66M -2.1M -10.23M -10.03M -8.37M -8.33M n/a
Shares Outstanding (Basic)
10.88K 256.4K 17.74K 11.5K 9.3K 6.66K 5.72K 4.48K 958.89 858.00 691.89 648.89 628.78 626.67 593.42 585.56 393.22
Shares Outstanding (Diluted)
10.88K 256.4K 17.74K 11.5K 9.3K 6.66K 5.72K 4.48K 958.89 858.00 691.89 648.89 628.78 626.67 593.42 585.56 393.22
EPS (Basic)
-1.26K -157.86 -931.66 -1.49K -1.92K -7.31K -17.83K -22.92K -48.16K -56.79K -66.36K -74.34K -111.48K -121.34K -120.33K -130.97K -95.62K
EPS (Diluted)
-1.26K -157.86 -931.66 -1.49K -1.92K -7.31K -17.83K -22.92K -48.16K -56.79K -66.36K -74.34K -111.48K -121.34K -120.33K -130.97K -95.62K
EBITDA
-15.56M -1.18M -9.05M -10.64M -5.62M -20.06M -25.85M -25.37M -36.06M -39.46M -43.04M -47.11M -75.41M -76.64M -69.56M -70.51M -34.35M
EBIT
-15.93M -1.56M -9.45M -10.93M -5.8M -20.24M -26.14M -25.77M -36.51M -40.52M -44.19M -48.35M -76.7M -77.51M -70.24M -71.02M -34.87M
Depreciation & Amortization
80K 84K 399K 286K 177K 179K 292K 409K 444K 1.06M 1.15M 1.24M 1.29M 869K 687K 512K 338K